Search
for
Sort by
Research 931–960 of 1000+
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Genetic Basis of Alopecia Areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Granzyme B in Autoimmune Skin Disease
- 3-Deoxysappanchalcone Promotes Proliferation of Human Hair Follicle Dermal Papilla Cells and Hair Growth in C57BL/6 Mice by Modulating WNT/β-Catenin and STAT Signaling
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- The Genetic Architecture of Alopecia Areata
- Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model
- Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle
- The association between rs2476601 polymorphism in PTPN22 gene and risk of alopecia areata
- MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata
- Dietary Habits in Japanese Patients with Alopecia Areata
- Alopecia areata
- Hair Follicle Stem Cells and Hair Regeneration
- Alopecia Areata of the Nails: Diagnosis and Management
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- Genome-Wide Association Study of Alopecia Areata in Taiwan: The Conflict Between Individuals and Hair Follicles
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Research Progress on the Immunomodulatory Effects by Dang Gui (Radix Angelica sinensis) and Its Active Chemical Components
- Role of Aire and Notch4 Allelic Mutations in Alopecia Areata in C3H/HeJ Mice
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions